D
uring the past decade, the use of osseointegrated implants as a foundation for prosthetic replacement of missing teeth has become highly predictable and successful. 1 However, certain risk factors might predispose individuals to lower success rates. 2 Survival of oral implants has been systematically analyzed in the 4th European Workshop on Periodontology in 2002. 1 It is evident that the survival of oral implants is very high. However, an initial loss of 2.5% of all implants is expected in routine implant therapy. After functional loading, implant loss was 2% to 3%, over a 5-year observation period for implants supporting fixed restorations, whereas in overdenture therapy, Ͼ5% of the implants were expected to be lost within that period.
Furthermore, Holm-Pedersen et al 3 reported that 0.5% to 1.3% implants are lost per year of function resulting in survival rates of between 80% and 90% after 10 years depending on the clinical situation of the implants and prosthetic rehabilitation. In a recent systematic review of the literature, it was found that smoking adversely affects implant survival and success and is more pronounced in areas of poor quality, trabecular bone. 2 Hultin et al 4 stated that there are few available studies evaluating the long-term effect of supportive periodontal programs for implant patients. The authors highlighted in their conclusions 4 the need for such studies to be initiated.
The purpose of this study was to evaluate the influence of smoking, diabetes mellitus, periodontitis, and supportive periodontal treatment as factors associated with long-term (up to 10 years) implant survival in a large cohort of patients who were in regular follow-up until data collection.
MATERIALS AND METHODS
The study population consisted of 475 patients (176 men, 37%; 299 women, 63%; average age 51.96 Ϯ 11.98) who were referred to a private clinic limited to Periodontics and Implantology between November 1995 and July 2006. A total of 1626 implants were placed by a single surgeon (R.A.) in these patients. Implants were placed after completion of periodontal causerelated therapy and periodontal stabilization. Follow-up ranged from 1 to 114 months (average 30.82 Ϯ 28.26 months).
All patients were offered a freeof-charge annual examination and follow-up after implant placement. Only patients who were in routine follow-up until data collection were included in the evaluation. Demographic parameters (age, gender, etc.) were similar between this follow-up group and the patients who were excluded because of their lack of adherence to follow-up appointments (data not shown).
Data were collected from patient files with regards to smoking habits, periodontal condition, diabetes mellitus, implant survival, and time when implant failure occurred. Patients were also divided into those who participated in a supportive periodontal program in the clinic and those who only attended the annual free-of-charge implant examination.
Data were analyzed with statistical software (SPSS 12.0; SPSS, Inc., Chicago, IL) using z test for proportions and 2 test. A 5% significance level was used.
RESULTS
Smoking was reported by 63 (13.2%) patients and diabetes mellitus by 49 (10.3%). Periodontal disease was diagnosed in 311 (65.4%) of the patients. Overall, 77 (4.7%) implants were lost in 58 (12.2%) patients after a mean period of 24.71 Ϯ 25.84 months.
In the structured supportive periodontal program in the clinic, 246 patients (51.7%) participated and 229 (48.3%) only attended the annual free-of-charge implant examination. Smoking and attendance in a regular supportive periodontal program were associated with implant survival (Table 1) . Patients with treated moderate-to-advanced chronic periodontal disease showed higher implant failure rates, but this difference did not reach statistical significance. Diabetes mellitus was not related to implant survival in this patient cohort ( Table 1 ). The odds ratio was 1.89 for attendance in a regular supportive periodontal program and smoking (P Ͻ 0.05) ( Table 2 ).
DISCUSSION
An implant-supported restoration offers a predictable treatment for tooth replacement. [7] [8] [9] Nevertheless, failures that mandate immediate implant removal do occur.
6,10Ϫ13 The consequences of implant removal jeopardize the clinician's efforts to accomplish satisfactory function and esthetics. For the patient, this usually involves further cost and additional procedures. 14 Reported predictors for implant success and failure are generally divided into patient-related factors (e.g., general patient health status, smoking habits, quantity and quality of bone, and oral hygiene maintenance), implant characteristics (e.g., dimensions, coating, and loading), implant location, and clinician experience.
15
The overall first-year survival rate for dental implants is between 92% and 97%. 16 An additional 1% of all implants that are initially successful and rehabilitated are lost every year because of complications. 17 In this study, the survival rates fall between the reported survival rates in the literature. 18 Hultin et al 4 conducted a study that systematically reviewed whether supportive implant treatment during a follow-up of at least 10 years after functional loading is effective in preventing biological complications and fixture loss. It was concluded that, to date, there are few available studies that evaluate the long-term effect of supportive programs for implant patients and that there is an urgent need for such studies to be initiated. This report clearly illustrates that there is an important role for regular continuous supportive periodontal therapy in implant patients to increase implant survival over time. In the treatment strategies for periodontitis, the need for supervised training and reenforcement of self-performed oral hygiene is well established. Also, in dental implant patients, instruction in brushing and interproximal cleaning should be initiated as soon as the prosthetic reconstruction is connected. In an elderly patient, reduced capacity of diligence and manual dexterity is not uncommon, thus requiring frequent professional training visits and cleaning of abutment surfaces to remove bacterial biofilms. Although there is no direct evidence in the literature to suggest the importance of supportive therapy for implants as for periodontally treated teeth, periodontal therapy has been suggested to precede implant therapy in partially dentate patients, 19 whereas systematic and continuous monitoring of the periodontal and peri-implant tissue conditions is suggested to prevent recurrence of periodontal disease and allow early diagnosis and treatment of periimplant diseases.
20
Other environmental-and patientrelated factors contribute to implant failures. Nitzan et al 21 report a relationship between marginal implant bone loss and smoking habits. A higher incidence of marginal implant bone loss was found in the smoking group, which was more pronounced in the maxilla. A higher degree of complications, or implant failure rates, were found in smokers with and without bone grafts. 22, 23 However, in an 18-month study of 1183 implants, Kumar et al 24 report similar survival rates (97% and 94.4%) for smokers and nonsmokers. In this study, smokers exhibited a significantly lower survival rate than nonsmokers. Smokers undergoing both implant-related surgical procedures and dental implantation should be encouraged by their dentists, oral and maxillofacial surgeons, or treating physicians to cease smoking, emphasizing that smoking can increase complications and reduce the success rate of these procedures.
Successful osseointegration has been shown in patients with different types of periodontitis. 25, 26 However, these reports do not offer comparative data between periodontally compromised patients who have been treated and periodontally healthy patients. Nevertheless, a systematic review by Van der Weijden et al 27 conclude that the outcome of implant therapy in periodontitis patients may be different compared with individuals without such a history in terms of loss of supporting bone and implant loss.
In a systematic review of implant outcomes in treated periodontitis subjects, Ong et al 20 conclude that there is some evidence that patients treated for periodontitis may experience more implant loss and complications around implants including higher bone loss and peri-implantitis than nonperiodontitis patients. Evidence was stronger for implant survival than implant success. In this report, periodontal disease patients demonstrated higher implant failure rates but this difference did not reach statistical significance, which could be attributed to the fact that the patients were treated in a periodontal clinic and their periodontal condition was "controlled." Consequently, appropriate consent should be obtained before implant therapy is provided to periodontal patients.
Diabetes mellitus is one of the most commonly encountered contraindications to dental implant therapy. Glycemic control is viewed as a critical variable in identifying whether patients with diabetes are eligible for implant therapy. 28 -30 This view on the importance of glycemic control in implant success has been reinforced.
31-33
Several clinical reports suggest that in patients with "well-controlled" type 2 diabetes mellitus, dental implant success rates (92%-100%) may not be significantly compromised. [32] [33] [34] In addition, a large multicenter study of dental implant success report an implant failure rate of only 7.8% for 255 implants placed in "selected" patients with type 2 diabetes mellitus.
31
The hypothesis that patients with diabetes are appropriate candidates for implants and that compromises in glycemic control may not exclude implant success has been explored. 35 This study found no evidence of diminished clinical success or significant early healing complications associated with implant therapy in patients with controlled type 2 diabetes mellitus, which agrees with the former study.
CONCLUSIONS
Smoking and attendance in a regular supportive periodontal program were found to be strongly related to implant survival. It is highly recommended to maintain implant patients under a strict supportive periodontal treatment protocol that might contribute to implant survival.
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The authors claim to have no financial interest in any company or any of the products mentioned in this article. Fumar, diabetes mellitus, periodontitis y tratamiento periodóntico de apoyo como factores asociados con la supervivencia de implantes dentales: Una evaluación retrospectiva de largo plazo en pacientes seguidos hasta 10 añ os ABSTRACTO: Propósito: Evaluar los factores asociados con la supervivencia a largo plazo de implantes en un grupo numeroso de pacientes en seguimientos normales hasta la recolección de datos. Métodos: La población del estudio consistió en 475 pacientes, derivados a una clínica privada limitada a periodóntica e implantología entre noviembre de 1995 y julio de 2006. Los datos se recolectaron de la historia del paciente con respecto a fumar, condición periodóntica, diabetes mellitus, supervivencia del implante y tiempo en el que falló el implante. Se dividió a los pacientes entre los que participaron en un programa periodóntico de apoyo en la clínica y los que solamente completaron el examen anual del implante gratis. Resultados: Se colocaron un total de 1626 implantes con un seguimiento que varió entre 1 y 114 meses (promedio 30.82 Ϯ 28.26 meses). En general, 77 (4.7%) implantes se perdieron en 58 (12.2%) pacientes luego de un período medio de 24.71 Ϯ 25.84 meses. Más de la mitad de los pacientes (246; 51.7%) participaron en un programa periodóntico de apoyo en la clínica y 229 (48.3%) solamente participaron en el examen anual del implante gratis. Fumar y concurrir a un programa regular periodóntico de apoyo estuvo estadísticamente asociado con la supervivencia de los implantes. Los pacientes con enfermedad periodóntica crónica moderada a avanzada (tratados) demostraron una tasa más alta de falla del implante, pero esta diferencia no alcanzó un nivel estadísticamente significativo. La diabetes mellitus no estuvo relacionada con la supervivencia de los implantes en este grupo de pacientes. Conclusiones: Se encontró que fumar y concurrir a un programa regular periodóntico de apoyo estaban altamente relacionados con la supervivencia del implante. Se deberá prestar atención especial a programas continuos periodónticos de apoyo para los pacientes con implantes. O tabagismo e o comparecimento a um programa periodontal de suporte regular foram estatisticamente associados à sobrevivência de implante. Os pacientes com doença periodontal crônica (tratada) moderada a avançada demonstraram taxas mais altas de falha de implante, mas essa diferença não alcançou significado estatístico. A diabete melito não estava relacionada à sobrevivência de implante nessa coorte de pacientes. Conclusões: Descobriu-se que o tabagismo e o comparecimento a um programa periodontal de suporte regular estavam fortemente relacionados à sobrevivência de implante. Especial atenção deve ser dada a programas periodontais de suporte contínuos para pacientes de implante.
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